Form D · Biotechnology
Kineticos Disruptor Fund AX6, LLC
Raleigh, NC · CIK 0001842957
Offering snapshot reported Feb 3, 2021 · SEC filing
- Reported sold
- $1.41M Offering amount: $1.41M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 22, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 3, 2021 | Initial | $1,414,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-388256
Source: Form D, filed Feb 3, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Abraham Surinder Maingi | Director, Executive |
| Shailesh Maingi | Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9131 Anson Way Suite 110
Raleigh, NC, 27615
Raleigh, NC, 27615